Perceptions of benefit noted in study. gan Cassandra P. Griffin (17684463)

Pynciau:

Included studies. gan Cassandra P. Griffin (17684463)

Pynciau:

Items included. gan Beatriz Goulão (16498275)

“...Four items reached consensus regarding critical importance for patient and public involvement: presentation of results to trial participants; summary and presentation of harms; interpretation and presentation of findings in an academic setting; factors impacting how well a treatment works. ...”

Flow of participants in the Delphi survey. gan Beatriz Goulão (16498275)

“...Four items reached consensus regarding critical importance for patient and public involvement: presentation of results to trial participants; summary and presentation of harms; interpretation and presentation of findings in an academic setting; factors impacting how well a treatment works. ...”

S1 Data - gan John Twomey (12595255)

Pynciau:

Prevalence of tweets over time in the dataset. gan John Twomey (12595255)

Pynciau:

Timeline of the use of deepfakes/synthetic media in the war. gan John Twomey (12595255)

Pynciau:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau:

Mean total number of benzodiazepine prescriptions administered by top prescribers at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau:

Mean rate (per 100) of new-start benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention–sensitivity analysis. gan Meagan Lacroix (16698830)

Pynciau:

Baseline characteristics of physicians and patients–prescribers in top 25 percent. gan Meagan Lacroix (16698830)

Pynciau:

Mean total number of benzodiazepine prescriptions administered by top prescribers at 12 months pre- to 18 months post-intervention–sensitivity analysis. gan Meagan Lacroix (16698830)

Pynciau:

Mean rate (per 100) of high-risk benzodiazepine prescriptions administered to patients >65 at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau:

Mean total number of benzodiazepine prescriptions administered at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau:

Mean rate (per 100) of high-risk benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau:

Mean total number of benzodiazepine prescriptions administered at 12 months pre- to 18 months post-intervention for patients > 65. gan Meagan Lacroix (16698830)

Pynciau:

Mean rate (per 100) of long-term benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention–sensitivity analysis. gan Meagan Lacroix (16698830)

Pynciau:

Mean rate (per 100) of new-start benzodiazepine prescriptions administered by top prescribing physicians at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau:

Estimates of percent change in slope of total benzodiazepine prescriptions after the intervention vs before. gan Meagan Lacroix (16698830)

Pynciau:

Mean rate (per 100) of high-risk benzodiazepine prescriptions at 12 months pre- to 18 months post-intervention. gan Meagan Lacroix (16698830)

Pynciau: